Broomfield physician Christopher Centeno has a bold prediction about one of the fastest-growing fields of medicine: Orthopedic surgery. “Most of what we currently call orthopedic surgery will, in the ...
WASHINGTON (CN) - Stem cell therapy for orthopedic patients constitutes a drug, opening manufacturers to liability for adulteration and misbranding, a federal judge ruled. The U.S. government sued ...
MELVILLE, N.Y., Dec. 05, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, ...
BioRestorative Therapies, Inc (NASDAQ: BRTX), a stem cell-based therapies clinical-stage company, forged an agreement with Regenexx, LLC, under which BRTX gets exclusive license rights for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results